The Saudi Food & Drug Authority (SFDA) released guidelines for Economic Evaluation Studies to assess...
Read moreIncrease in net spending and challenges in balancing healthcare budgets highlighted in AIFA's latest...
Read moreNew doctrine accelerates drug development for rare diseases and oncology by adjusting evidence requi...
Read moreGermany's new Medicines Research Act allows confidential rebates for pharma companies, but recent am...
Read moreNew ground-breaking gene therapy for haemophilia B enters NHS England's Innovative Medicines Fund, o...
Read moreThe rise of personalised medicine is revolutionizing healthcare, prompting a re-evaluation of tradit...
Read moreWe discuss the updates on EU HTA from the June meeting of the Member State Coordination Group on Hea...
Read moreScottish Medicines Consortium approves the use of obesity treatment under the NHS in UK first, whils...
Read moreNHS and NICE propose faster adoption of MedTech, streamlining funding and market access for innovati...
Read moreThe German government’s proposal to keep negotiated confidential rebates was rejected by the feder...
Read more